BCRX
BIOCRYST PHARMACEUTICALS INC
Key Financials
Operating Income
$341.0M
↑ 13508.9%
Net Income
$263.9M
↑ 396.9%
EPS (Diluted)
$1.21
↑ 381.4%
Revenue
$25.2M
↓ 4.4%
Total Assets
$514.2M
↑ 4.8%
Shareholders' Equity
$-119153000.00
↑ 75.0%
Total Liabilities
$633.3M
↓ 34.5%
Long-term Debt
$0.00
↓ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCRX |
| Company Name | BIOCRYST PHARMACEUTICALS INC |
| CIK | 882796 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 919-859-1302 |